ClinicalTrials.gg
CompletedNCT04539353Updated Nov 20, 2026

HRV and Pain Intensity

An observational study in Chronic Pain, sponsored by Moens Maarten. Completed at 2 sites in Belgium. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-20.

Sponsored by Moens Maarten · Observational

How we know

Updated Nov 20, 2026Now CompletedResults publication added+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
366
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 79 studies in Chronic Pain with a site in Belgium — 18 open to participants now, 21 under way, none of them phase 3. Chronic Pain · Belgium.

Enrollment
10th of 32
366 · median 167
Started
2020
with 8 others
Observational
32 of 79
11 open now
Registered
44th of 79
by date
Lead sponsor
3 of 79
Moens Maarten

Among the 79 studies in Chronic Pain with a site in Belgium, this one is the 10th largest by enrollment of the 32 observational ones that give a count, is one of 9 that started in 2020, is one of 32 observational ones, and was the 44th registered.

Chronic Pain

3,230 studies on the registry are indexed under Chronic Pain; 728 are open to participants now.

Browse Chronic Pain studies →

Open to participants now

18 of the 79 studies in Chronic Pain with a site in Belgium are open now. Recruiting first, the newest first:

13 more — sign in →

All 18 open studies →

A study can be open while its sites in Belgium have not opened yet or have stopped. Only those recruiting at a site in Belgium →

Who these studies take

Of the 486 Chronic Pain studies recruiting now, 239 (49%) set no upper age limit and 173 (36%) stop at 75 or younger; 43 take children under 18; 64 take healthy volunteers.

This study: 18 Years and older · all sexes.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 79 studies in Chronic Pain with a site in Belgium, or all of them as a file.
02

Study summary

The aim of this study is to explore the association between pain intensity and heart rate variability in patients with chronic pain.

03

Conditions studied

  • Chronic Pain

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Chronic pain patients (regardless of the cause of the pain).

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with chronic pain for at least 3 months
  • Age > 18 years
  • Patient has been informed of the study procedures and has given written
  • Patient willing to comply with study protocol

Exclusion criteria

Exclusion Criteria:

  • Healthy patients or patients with acute pain.
  • Evidence of an active disruptive psychiatric disorder that may impact perception of pain, and/or ability to evaluate treatment outcome as determined by investigator
  • Patients were excluded if they had one or more coexisting conditions known to affect HRV analysis.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
366 participants (actual)
Patient registry
No

Groups and cohorts

  • chronic pain

    Patients with chronic pain, regardless of the cause of the pain.

    Other: Heart Rate Variability · Other: Pain intensity

Interventions

  • OtherHeart Rate Variability

    Heart Rate Variability will be measured with a Polar device.

  • OtherPain intensity

    Pain Intensity will be measured with a Numeric Rating Scale and Visual Analogue Scale

06

What researchers measure

Primary outcomes

  1. Heart Rate Variability

    Heart Rate Variability will be measured with a Polar device during a 5 minute recording.

    Time frame: During study visit, cross-sectional, once, during 5 minutes.

  2. Pain Intensity with Numeric Rating Scale

    Pain Intensity will be measured with a Numeric Rating Scale.

    Time frame: During study visit, cross-sectional, once.

  3. Pain Intensity with Visual Analogue Scale

    Pain Intensity will be measured with a Visual Analogue Scale.

    Time frame: During study visit, cross-sectional, once.

07

Study locations

2 sites
  • Universitair Ziekenhuis Brussel
    Jette, 1090, Belgium
  • AZ Delta
    Roeselare, 8800, Belgium
08

References and documents

Publications

  • Goudman L, Pilitsis JG, Billet B, De Vos R, Hanssens K, Billot M, Roulaud M, Rigoard P, Moens M. The level of agreement between the numerical rating scale and visual analogue scale for assessing pain intensity in adults with chronic pain. Anaesthesia. 2024 Feb;79(2):128-138. doi: 10.1111/anae.16151. Epub 2023 Dec 6. PubMed 38058100 ↗
  • Moens M, Billet B, Molenberghs G, De Smedt A, Pilitsis JG, De Vos R, Hanssens K, Billot M, Roulaud M, Rigoard P, Goudman L. Heart rate variability is not suitable as a surrogate marker for pain intensity in patients with chronic pain. Pain. 2023 Aug 1;164(8):1741-1749. doi: 10.1097/j.pain.0000000000002868. Epub 2023 Jan 19. PubMed 36722463 ↗
09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Dec 2020 to primary completion in Oct 2021, 10 months.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 26, 2020
First posted
Sep 7, 2020
StartActual
Dec 14, 2020
Primary completionActual
Oct 25, 2021
CompletionActual
Oct 25, 2021
Last update
Nov 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Status unknown→Completed
changed Nov 20, 2026
Primary completion
Oct 15, 2021→Oct 25, 2021 (actual)
Nov 20, 2026
Study completion
Oct 15, 2021→Oct 25, 2021 (actual)
Nov 20, 2026
Enrollment
200 (estimated)→366 (actual)
Nov 20, 2026
Publications
Results publication added: Goudman L, Pilitsis JG, Billet B, De Vos R, Hanssens K, Billot M, Roulaud M, Rigoard P, Moens M. The level of agreement between the numerical rating scale and… PubMed 38058100 ↗; 1 more
Nov 20, 2026
Show all 1 update
  1. Nov 20, 2026
    Status unknown→Completed
    Publications Results publication added: Goudman L, Pilitsis JG, Billet B, De Vos R, Hanssens K, Billot M, Roulaud M, Rigoard P, Moens M. The level of agreement between the numerical rating scale and… PubMed 38058100 ↗; 1 more
    Primary completion Oct 15, 2021→Oct 25, 2021 (now actual)
    Study completion Oct 15, 2021→Oct 25, 2021 (now actual)
    Enrollment 200 (estimated)→366 (actual)
    + 3 other changes: verification date, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT04539353
Lead sponsor
Moens Maarten
Responsible party
Moens Maarten (principal investigator, Universitair Ziekenhuis Brussel) — Sponsor-investigator
First posted
Sep 7, 2020
Start date
Dec 14, 2020
Primary completion
Oct 25, 2021
Completion
Oct 25, 2021
Last update
Nov 20, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion